Log in to search using one of your social media accounts:

 

Evening primrose oil and labour, is it effective? A randomised clinical trial.

Evening primrose oil and labour, is it effective? A randomised clinical trial. J Obstet Gynaecol. 2018 Feb 09;:1-5 Authors: Kalati M, Kashanian M, Jahdi F, Naseri M, Haghani H, Sheikhansari N Abstract The purpose of the present study was to evaluate the effects of evening primrose oil (EvPO) on the duration of pregnancy and labour. The study was performed as a triple blind placebo controlled randomised clinical trial on nulliparous low-risk women with a certain gestational age of 40 weeks of pregnancy and a Bishop score of less than 4. In the case group (EvPO group), EvPO capsules were administered, 1000 mg, twice daily, for 7 days, and in the control group, placebo was administered similarly. The women of the two groups were followed up to delivery. In total, 80 women finished the study (40 in each group). The women of the two groups did not have significant differences according to age, BMI, Bishop Score at the beginning of the study, gestational age at entering the study, employment status and education level, the number of capsules used and duration of using medications. There was no significant difference between the two groups according to gestational age at delivery, need for induction or augmentation of labour, duration of different stages of labour, neonatal weight and Apgar scores, and the indications for hospital admission. Impact statement What is already known on this subject? Evening primrose oil has been used for the tr...
Source: Journal of Obstetrics and Gynaecology - Category: OBGYN Tags: J Obstet Gynaecol Source Type: research

Related Links:

Authors: Matsen FA PMID: 29461306 [PubMed - as supplied by publisher]
Source: The Journal of the American Academy of Orthopaedic Surgeons - Category: Orthopaedics Tags: J Am Acad Orthop Surg Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
AbstractObjective:To assess the impact of discontinuing oral hormone therapy (HT) on sexual activity, vaginal symptoms, and sexual activity components among participants in the estrogen-progestin therapy (EPT) and estrogen therapy (ET) trial of the Women's Health Initiative.Methods:Surveys were sent postintervention to those who were still taking study pills and agreed to continue in the study when the trials were stopped. Comparisons between former HT and placebo users were accomplished with chi-square tests for categorical variables and t tests for continuous variables.Results:In all, 13,902 women with mean age at survey...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions:These findings provide a national estimate of ANM in Canada and show the importance of lifestyle factors and health conditions in determining menopausal age. These factors might help in risk assessment, prevention and early management of chronic disease risk during the menopausal transition. Background: Early onset of menopause is associated with long-term disease and higher mortality risks. Research suggests that age at natural menopause (ANM) varies across populations. Little is known about factors that affect ANM in Canadian women. Objective: This study aims to estimate the median ANM and examine fact...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
AbstractObjective:The aim of the study was to explore dose-related endometrial effects of conjugated estrogens/bazedoxifene (CE/BZA).Methods:In this randomized, double-blind, phase 2 study, 408 nonhysterectomized, symptomatic (with hot flushes [HFs]) postmenopausal women received ≥1 dose of CE 0.3 or 0.625 mg alone or with BZA 5, 10, or 20 mg/d; placebo; BZA 5 mg/d alone; or CE 0.625 mg with medroxyprogesterone acetate 2.5 mg/d for 84 days. The primary outcome was endometrial thickness on transvaginal ultrasound. HF frequency and severity based on diaries were key secondary outcomes.Results:CE 0.625 mg alone...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions:In this qualitative study, women described experiencing both positive and negative changes in sexual function during midlife. When negative changes occurred, women often adapted behaviorally and psychologically. Providers should recognize that each woman's experience is unique and nuanced, and they should provide tailored care regarding sexual function at midlife. Objective: Women experience a variety of changes at midlife that may affect sexual function. Qualitative research approaches can allow a deeper understanding of women's experiences. We conducted 20 individual interviews and three focus groups amon...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
AbstractObjective:The aim of the study was to determine the range of serum sex-related steroids in normal postmenopausal women and in women of the same age with a diagnosis of vulvovaginal atrophy (VVA).Methods:Validated mass spectrometry-based assays coupled to gas or liquid chromatography were used over a 10-year period for steroid measurements. Serum samples were obtained in up to 1,512 women aged 55 to 65 years.Results:Serum estrone sulfate (E1S) and androsterone glucuronide (ADT-G), the main metabolites of estrogens and androgens, respectively, were 16.9% (P = 0.005) and 16.1% (P = 0.001) higher in women not d...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions:Calcium plus vitamin D supplementation combined with specifically oriented exercises had a higher impact in the femoral neck than walking at an intense pace. As there were no differences at the lumbar spine level, the results were, however, inconclusive concerning which type of exercise was the most convenient. Importantly, the fact that the T-scores did not decrease after 2 years supports the belief that both proposed interventions can be conveniently used to prevent osteoporosis in postmenopausal women. A trial with a larger sample size would provide consistency to the findings and is warranted given the poss...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Arthritis | Chronic Pain | Clinical Trials | Dermatitis | Dermatology | Education | Employment | Evening Primrose | Eyes | Hospitals | Induction of Labor | Men | Menopause | OBGYN | Pain | Perinatology & Neonatology | Pregnancy | Psoriasis | Rheumatoid Arthritis | Rheumatology | Study | Universities & Medical Training | Women